Post by Nicola McConville

My colleague Charlie Fletcher has articulately summarised the basis of so many conversations I am hearing from a diverse range of life science companies across the arc and beyond at the moment. It’s certainly a tough time out there (lost count of the comment that a flat round is the new up round?), but equally we are heartened to see some great deals landing for long standing clients like Relation, Quell and Vice Bio where Patrick Farrant and his team come into their own in optimising those IP assets and opportunities.